Tolerance to or facilitation of pharmacological effects induced by chronic treatment with the beta-adrenergic stimulant clenbuterol

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of neural transmission

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/BF01260416PMID 4020382
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antagonism of reserpine-induced hypothermia in mice by some beta-adrenoceptor agonists.

  2009cited by this paper
• The effect of chronic treatment with antidepressant drugs on salbutamol-induced hypoactivity in rats

  2004cited by this paper
• Subsensitivity of human β-adrenergic adenylate cyclase after salbutamol treatment of depression

  2004cited by this paper
• The validity of animal models of depression

  2004cited by this paper
• Determination of clenbuterol in the high nanogram range in plasma of mice by high-performance liquid chromatography with amperometric detection.

  1984cited by this paper
• Chronic treatment with electroconvulsive shock prevents the salbutamol‐induced hypoactivity in rats

  1984cited by this paper
• Beta-receptor stimulation in the treatment of depression.

  1984cited by this paper
• Stimulation of beta-adrenergic receptors and spontaneous motor activity in mice.

  1984cited by this paper
• Disappearance of the decrease in biting behavior induced by clenbuterol, a beta-adrenergic agonist, after chronic administration.

  1984cited by this paper
• Potentiation of yohimbine‐induced lethality in mice: Predictor of antidepressant potential

  1983cited by this paper
• The value of the reserpine test in psychopharmacology.

  1983cited by this paper
• Subchronic infusion of clenbuterol, a beta-adrenergic agonist, decreases the cerebellar beta receptor.

  1983cited by this paper
• β-Adrenoceptor de sensitization in rat lung: Functional and biochemical aspects

  1983cited by this paper
• Beta-adrenoceptor desensitization in rat lung: functional and biochemical aspects.

  1983cited by this paper
• beta-Adrenergic tachyphylaxis in the rat and its reversal and prevention by ketotifen.

  1983cited by this paper
• Evidence that systemically administered salbutamol reduces food intake in rats by acting on central beta-adrenergic sites.

  1982cited by this paper
• Mechanisms of beta-adrenergic desensitization in rat myometrium.

  1981cited by this paper
• The central action of salbutamol, a beta-agonist with a potential antidepressant activity.

  1980cited by this paper
• Clenbuterol, a central beta-adrenoceptor agonist.

  1980cited by this paper
• A Beta Adrenergic Stimulant (Salbutamol) versus Clomipramine in Depression: A Controlled Study

  1980cited by this paper
• Agonist-induced changes in beta adrenergic receptor density and receptor-mediated responsiveness in slices of rat cerebral cortex.

  1979cited by this paper
• In vitro modulation of CNS β-receptor number by antidepressants and β-agonists

  1979cited by this paper
• In vitro modulation of CNS beta-receptor number by antidepressants and beta-agonists.

  1979cited by this paper
• Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment.

  1979cited by this paper
• Antagonism by d,1-propranolol of imipramine effects in mice.

  1979cited by this paper
• Experimental and clinical evidence of the antidepressant effect of a beta-adrenergic stimulant

  1978cited by this paper
• [A new approach to the treatment of depression: salbutamol].

  1978cited by this paper
• 2447 – ACTION DE MEDICAMENTS PSYCHOTROPES SUR UN TEST DE COMPORTEMENT CHEZ LA SOURIS (“TEST DE TANTALE”)

  1978cited by this paper
• Development of β-adrenergic receptor subsensitivity by antidepressants

  1977cited by this paper
• Mechanism of isoproterenol-induced desensitization of tracheal smooth muscle.

  1977cited by this paper
• Development of beta-adrenergic receptor subsensitivity by antidepressants.

  1977cited by this paper
• Tachyphylaxis to β-adrenoceptor agonists in guinea pig airway smooth muscle in vivo and in vitro

  1977cited by this paper
• Tachyphylaxis to beta-adrenoceptor agonists in guinea pig airway smooth muscle in vivo and in vitro.

  1977cited by this paper
• Adrenaline-induced desensitization of liver adenylate cyclase.

  1976cited by this paper
• Agonist-specific refractoriness induced by isoproterenol. Studies with mutant cells.

  1976cited by this paper
• Ingestion in the satiated rat: role of alpha and beta receptors in mediating effects of hypothalamic adrenergic stimulation.

  1975cited by this paper
• Subsensitivity of adenylate cyclase and decreased beta-adrenergic receptor binding after chronic exposure to (minus)-isoproterenol in vitro.

  1975cited by this paper
• Letter: Studies of resistance to long-acting adrenergic beta-stimulators in asthmatic patients.

  1974cited by this paper
• Observations on the ontogeny of the feeding response to adrenergic agonists and antagonists.

  1973cited by this paper
• Resistance to β‐adrenoceptor stimulants (a possible explanation for the rise in asthma deaths)

  1971cited by this paper
• [USE OF A PARTICULAR MOUSE REACTION (HOLE BOARD METHOD) FOR THE STUDY OF PSYCHOTROPIC DRUGS].

  1964cited by this paper

• An Overview of Doping in Sports

  2019cites this paper
• Chronic beta-adrenergic stimulation increases in mice the sensitivity to methysergide and the number of cerebral high affinity serotonin binding sites (5-HT-1)

  2005cites this paper
• Lesions of the serotonergic system impair the facilitation of but not the tolerance to the effects of chronic clenbuterol administration

  2004cites this paper
• Myotoxic effects of clenbuterol in the rat heart and soleus muscle.

  2002cites this paper
• Reserpine-induced hypothermia: participation of beta 1 and beta 2 adrenergic receptors.

  1987cites this paper
• Beta-adrenergic agonists reduce spontaneous motor activity through either beta 1 or beta 2 receptors.

  1987cites this paper
• The pharmacological effects of acute and chronic clenbuterol treatments after lesions of central noradrenergic nerve terminals.

  1986cites this paper
• Chronic clenbuterol treatment modulates a 5‐hydroxytryptaminergic system

  1986cites this paper
• The effect of a beta-adrenergic agonist on behaviors mediated by 5-HT1A and 5-HT1B receptors.

  1986cites this paper